Exact Sciences Corporation (EXAS)

59,59 -0,42 (-0,70%) Ab 11:06AM EDT. Markt geöffnet.

Exact Sciences Corporation

5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700
https://www.exactsciences.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 6.500

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Kevin T. Conroy	Chairman of The Board & CEO	3,14M	N/A	1966
Mr. Jeffrey T. Elliott CFA	EVP & CFO	1,13M	N/A	1978
Mr. Jake Orville MBA	Executive VP & General Manager of Pipeline	1,04M	N/A	1974
Mr. Everett V. Cunningham	Chief Commercial Officer & Executive VP	1,6M	N/A	1966
Mr. Brian Baranick	Executive VP & General Manager of Precision Oncology	942,89k	N/A	1978
Dr. Jorge A. Garces Ph.D.	Chief Science Officer	N/A	N/A	1972
Mr. Nassar Nizami	Chief Information Officer	N/A	N/A	N/A
Ms. Megan Jones	Associate Manager of Investor Relations	N/A	N/A	N/A
Mr. Tim Caprez	Chief Compliance Counsel & VP	N/A	N/A	N/A
Mr. James Herriott	Senior VP, General Counsel & Secretary	N/A	N/A	1980

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporations ISS Governance QualityScore, Stand 29. April 2024, lautet 3. Die grundlegenden Scores sind Audit: 1, Vorstand: 4, Shareholderrechte: 3, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.